KOP Philanthropic Proudly Presents

the quest for a cure campaign

Help us redefine cancer care

JOIN THE BENCH-TO-BEDSIDE JOURNEY AND SUPPORT OUR QUEST TO SILENCE CANCER ONCE AND FOR ALL WITH OUR NEWLY DISCOVERED CANCER CELL THERAPY.

WHO WE ARE

SIDNEY KIMMEL CANCER CENTER - THOMAS JEFFERSON UNIVERSITY IN PARTNERSHIP WITH KOP PHILANTHROPIC

THE SCIENCE

Silence Cancer by Controlling the Cancer Genes. The KOP AI-enabled Drug Platform contains two active components. One that drives the drug selectively to cancer cells and the second, the genetic component, that blocks the bad copies of the mutated cancer gene inside the cells, thus Preventing Cancer Growth and ultimately causing the cancer cell to die.

the visionaries

Dr. Thakur and Dr. Wickstrom are world experts in cancer biology. Combined Professors Thakur and Wickstrom have 700+ peer-reviewed papers, patents, reviews, and chapters with 6 books on molecular design, nucleic acid structure, gene function, mRNA translation, protein structure and cell biology. They are truly the rockstars in their field of study.

Get Involved

Sidney Kimmel Cancer Center – Thomas Jefferson University in partnership with KOP Therapeutics share the Philanthropic Vision: $5 Million Dollars Goal to Reach FDA Approved Human Trials by 2023. Let's reimagine the future of Cancer Care together. Thank you for your thoughtful consideration of this transformational gift. Join the Power of Philanthropy.

JOIN THE CAUSE

Get involved where it matters

Connect with KOP, SKCC & TJU and make a real difference to the lives of those who suffer from cancer with our low toxicity KOP-101 Drug Therapy Research & Development.

Get Involved

Your generosity makes our work possible. Whether you contribute financially with a donation or as a KOP “Quest for a Cure Campaign” Ambassador, the leading edge science breakthrough is yours to discover and share with your colleagues, family & friends.

Learn more about our cause

Book your virtual tour of Thomas Jefferson University – Sidney Kimmel Cancer Center. Go behind the scenes to the Labs of Dr. Thakur & Dr. Wickstrom.

BOOK A ViRTUAL TOUR

Our motto

HOPE IS EVERYTHING!

Your generosity makes our work possible. Whether you contribute financially or as an advocate for better cancer care treatments, you can make a real and lasting difference.

Your kind donation to KOP’s “Quest for a Cure Campaign makes the bench-to-bedside journey to FDA Approved Human Trials by 2023 more attainable. Help Redefine Cancer Care.

START NOW

TWO BRILLIANT MINDS ONE SHARED VISION

The “Quest for a Cure Campaign” is built on Dr. Thakur’s and Dr. Wickstrom’s hope to redefine cancer care and determination to share their vision with the world. By combining their respective specialized fields of study, radiopharmaceutical research & molecular imaging with biochemistry and molecular biology, these two world renowned experts stand to revolutionize the future of cancer care. The culmination of their life’s work led to the creation of the KOP-101 Drug therapy for cancer. Your generous gifts and contributions are directly assigned to Dr. Thakur and Dr. Wickstrom’s Research & Development Fund.

WE ARE HERE TO HELP!

CONTACT OUR PHILANTHROPIC TEAM

SIDNEY KIMMEL CANCER CENTER

Emma Laverty

Assistant Vice President of Development, Sidney Kimmel Cancer Center and Clinical Programs

Office of Institutional Advancement

Thomas Jefferson University and Jefferson Health

125 S. 9th Street, Suite 600 | Philadelphia, PA 19107

Phone: 215-503-8679 (o) 215-519-7126

Email: Emma.Laverty@jefferson.edu

Website: www.kopphilanthropic.com

get involved

how you can help

Make a gift

Your generosity makes our research advancements possible. Whether you contribute financially or as advocate for the QUEST FOR A CURE CAMPAIGN. Every Dollar counts, we thank you in advance for your kind generosity.

social media quest for a cure campaign

Support our social media campaign Please Visit our KOP Philanthropic Facebook Page and give us a Like. Share your stories, join our KOP Community in the Quest for a cure campaign.

Join our Efforts

Share your stories and join our community in the fight to Silence Cancer Once and For All. Visit our website for more information on the science and detailed milestones to FDA Approved Human Trials in 2023. www.koptherapeutics.com

LATEST STORIES

Sidney Kimmel Cancer Center
Giving FAQs:
https://giving.jefferson.edu/ways-to=give/giving-fact.html

Sidney Kimmel Cancer Center at Thomas Jefferson University Stands Out Video:
https://Youtu.be/RZ_Yc7Y_Epg

Thomas Jefferson University / Jefferson Health
Reimagine: The Campaign for Jefferson
https://www.youtube.com/watch?v=FmLdrabOHjI

KOP Therapeutics
KOP-101 Drug Cancer Cell Therapy
www.koptherapeutics.com

cancer facts & stats

NEW CANCER CASES IN THE USA

5285

WORLDWIDE CASES

GLOBAL CANCER DEATHS

(Statistic Referenced @2019 American Cancer Society, Inc.)

OUR PARTNERS

SUBSCRIBE AND JOIN OUR PHILANTHROPIC COMMUNITY

Facebook

DISCLAIMER

The information contained in this presentation is in summary form only, is not intended to be complete and may contain inadvertent or unintentional errors. No representation, warranty or guarantee, expressed or implied, is made as to the fairness, accuracy or completeness of information contained herein, including the accuracy, likelihood of achievement or reasonableness of any forecasts, prospects, results or statements in relation to future matters contained in this presentation. This presentation does not constitute an offer to sell or the solicitation of an offer to buy any security and is not intended to be relied upon as advice to investors or potential investors. KOP is not liable to any recipient or third party for the use of or reliance on the information contained in this presentation.

COPYRIGHT AND TRADEMARK

The information in this presentation ( including certain names, graphics, logos, icons, designs, words, titles or phrases) is protected by copyright and other laws and may not be copied, reproduced, modified, uploaded, posted, transmitted, or distributed in any way without KOP’ s prior written approval. Any unauthorized downloading, re-transmission, re-publication or other copying or modification of trademarks and/or the contents herein is strictly prohibited